The flare is gone. The redness faded. The itch stopped. But the skin where it happened is darker than everything around it, and it has been that way through the last three episodes. Each time the eczema clears, it clears to a slightly deeper brown than before. You are not imagining that.
The dark mark left behind by a flare is not scarring. It is pigment that your melanocytes produced in response to the inflammation. And when the flares keep returning to the same area, the pigment does not just reset between episodes. It accumulates.
What follows explains the mechanism. Once you see why it compounds, the logic of what to do about it becomes much clearer.
What happens to melanocytes during a flare
An eczema or dermatitis flare is, at its core, an inflammatory event. The immune system activates in the affected area. T-cells flood in. Mast cells degranulate. Inflammatory signalling molecules fill the local tissue.
Your melanocytes are sitting right next to where this is happening.
They are not part of the immune response. They have no role in fighting whatever triggered the flare. But they are sensitive to many of the same chemical signals. Prostaglandins released during the flare stimulate the enzyme that drives melanin production. Endothelin-1, produced by stressed skin cells, keeps that activation going after the acute phase subsides. TNF-alpha, one of the central inflammatory cytokines in eczema, upregulates melanogenesis through its own separate pathway.
The melanocytes do not need a specific instruction to make pigment. They respond to the inflammatory environment as a whole. The more intense the flare and the longer it lasts, the more signalling reaches them, and the more melanin they produce at that site.
The darkest marks tend to appear where the flares were most severe. Not where they lasted the longest. Not where you scratched the hardest. Severity of inflammation is the primary driver.
Though scratching makes it worse. We will get to that.
Why repeated flares deepen the marks
A single flare in skin that has never been inflamed before behaves like any other post-inflammatory mark. Inflammation activates melanocytes, pigment is deposited, and once the flare resolves, the mark begins to fade through normal skin turnover. Given enough time and no recurrence, it clears.
Eczema does not give the skin that time.
When a flare recurs in the same location, the melanocytes at that site are reactivated before they have fully returned to their resting state. Each cycle of inflammation adds pigment on top of what was still fading from the last one. The mark that was halfway to clearing gets pushed back to full intensity and beyond, because the melanocytes are now responding from a higher starting point.
Over multiple cycles, something shifts. The melanocytes in chronically flared areas become sensitised. They develop a lower activation threshold. A mild flare that would produce no visible pigment in fresh skin now produces measurable darkening in skin that has been through several inflammatory cycles.
Each flare is not independent. It is the next iteration of a pattern that has progressively trained the melanocytes at that site to overrespond.
This is why the marks get darker over time even when the flares themselves are not getting worse.
The barrier problem between flares
Here is the part that is easy to miss.
Eczema-prone skin does not have a normal barrier, even when it looks calm. Ceramide levels are reduced. The lipid matrix that holds skin cells together is disorganised. Water escapes more easily. This is not damage from the last flare. It is a baseline feature of the condition.
A damaged barrier means the skin between flares is not actually resting. It is more permeable to UV. More reactive to irritants that intact skin would shrug off. More likely to mount a low-grade inflammatory response to things that should not provoke one. Each of those micro-reactions sends a small amount of inflammatory signalling to the melanocytes that are already sensitised from the last flare.
The cycle works like this: the flare damages the barrier further. The damaged barrier lets more triggers through. Those triggers produce low-level inflammation between flares. That inflammation keeps melanocytes primed. When the next flare arrives, it arrives in skin that was never truly calm.
Breaking the pigment cycle requires breaking the barrier cycle. If the barrier is not repaired between flares, the intervals are still contributing to pigment accumulation even when no visible inflammation is present.
Why scratching compounds the response
The itch-scratch cycle is not just a comfort problem. It has direct pigment consequences.
Scratching inflamed skin introduces mechanical trauma on top of an existing inflammatory response. The physical force ruptures cells, creates micro-tears, and triggers its own inflammatory signalling independently of the eczema. The melanocytes now receive input from two sources: the underlying flare and the surface damage from scratching.
Chronic rubbing or scratching in the same area, even at low intensity, can produce progressive thickening and darkening of the skin. The pigmentation in these areas becomes particularly stubborn because the mechanical stimulus is ongoing and the melanocyte activation is sustained by repetition rather than intensity.
Friction from clothing over affected areas, habitual touching, or repeated wiping produces a milder version of the same effect. Any sustained mechanical input to sensitised skin adds to the load.
The steroid complication
Topical corticosteroids are the standard treatment for eczema flares. They suppress the inflammatory response effectively, and by reducing inflammation, they reduce the pigment response. In most flares, treating promptly with an appropriate steroid produces a better pigment outcome than leaving the inflammation to run its course.
Untreated inflammation is worse for pigment than treated inflammation. That part is straightforward.
The complication is prolonged use. Extended application of potent topical steroids thins the skin. The epidermis becomes more fragile, the barrier degrades further, and the skin's ability to recover between flares decreases. Thinned skin is more vulnerable to UV, more reactive to irritants, and less resilient when the next flare arrives. The treatment that suppressed the acute inflammation can, over time, create conditions that make subsequent flares produce more pigment.
Steroid withdrawal can also trigger rebound flares. When the suppressed inflammation returns into skin that is now thinner and less resilient, the pigment response can be stronger to the flare's apparent severity.
Separately, prolonged steroid use can lighten the skin at the application site. This is a direct effect on melanocyte function, distinct from PIH. The two can coexist in the same person: lightened patches where steroids were overused and darkened patches where inflammation was active. It looks contradictory, but they are different mechanisms.
None of this is a reason to avoid steroids. It is a reason to use them with a plan. Potency matching, duration limits, and a clear transition from flare treatment to maintenance care. That conversation belongs with a dermatologist who understands both the eczema and the pigmentation.
Skin tone and the scale of the response
In darker skin tones, Fitzpatrick IV to VI, melanocytes are more responsive to inflammatory signals at baseline. The same flare severity produces a proportionally larger pigment response. This is why eczema-related PIH is more visible and more persistent in melanin-rich skin, even when the underlying condition is identical in severity.
But skin tone is not the whole picture.
How much pigment any given flare produces depends on what the melanocytes were doing when it arrived. If background inflammation is elevated (from stress, poor sleep, dietary triggers, hormonal shifts, or the condition itself being inadequately controlled), the melanocytes are already operating above their resting level. The next flare does not start from zero. It starts from wherever the background pushed them to, and the pigment response reflects the full load, not just the individual event.
If your flares have started producing more pigment than they used to, and the flares themselves have not changed in severity, the background may have shifted.
What determines whether the skin resets between flares
The interval between flares is where the pigment trajectory is decided. If the skin can return to a genuine low-inflammation baseline, repair its barrier, and let melanocyte activity settle, the pigment from the previous flare fades normally and the next cycle starts from a lower accumulation point. If it cannot, each cycle compounds.
Three things govern that reset.
Barrier repair depends on the building blocks the skin needs to reconstruct its lipid matrix: ceramides, cholesterol, and free fatty acids. These are made locally but depend on systemic nutrient availability. When the raw materials are insufficient, barrier recovery is slower and the window of vulnerability between flares stays open longer.
Inflammatory resolution, the active process by which the immune system switches from attack mode to repair mode, depends on specialised pro-resolving mediators derived from omega-3 fatty acids. When these substrates are depleted, inflammation does not shut off cleanly. It smoulders. The melanocytes continue receiving low-level signals even after the visible flare has passed.
Antioxidant capacity determines how much of the oxidative stress generated during each flare reaches the melanocyte signalling threshold. Glutathione and vitamin C are the primary buffers. When reserves are low, more oxidative stress gets through, and your melanocytes respond more intensely to each flare.
Kallistia's internal support is designed around these three recovery variables. For eczema-related pigmentation, the internal layer is not about treating the condition or fading marks directly. It is about giving the skin the systemic resources it needs to actually achieve a calm baseline between episodes, so each flare is an isolated event rather than the next step in a compounding cycle.
